Skip to content

Evaluation of chemotherapy combined with HIFU in the treatment of recurrent and drug-resistant GTN

Evaluation of chemotherapy combined with HIFU in the treatment of recurrent and drug-resistant GTN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058287
Enrollment
Unknown
Registered
2022-04-04
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational trophoblastic tumor

Interventions

control group:Chemotherapy combined with HIFU

Sponsors

The Third Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: All cases were clinically or histologically diagnosed as GTN; v did not receive chemotherapy, radiotherapy and concurrent chemoradiotherapy before admission; v all patients have no other immune system diseases and no history of other tumors; v patients are willing and able to provide written informed consent before participating in this study; v women in childbearing period with informed consent; If any of the inclusion criteria is "no", the patient cannot participate in the experiment.

Exclusion criteria

Exclusion criteria: Complicated with serious internal and external diseases, such as blood system diseases; v those who have no fertility requirements and require surgical hysterectomy; v second primary cancer in other parts at the time of diagnosis; v cases with incomplete pathological and follow-up data and extensive systemic metastasis; v participating in or having participated in any other clinical trials in the past three months.

Design outcomes

Primary

MeasureTime frame
Human chorionic gonadotropin;Course of treatment required for CR;

Countries

China

Contacts

Public ContactXiaoyun Liu
656479556@qq.com0851-28925630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026